Starbucks confirms it will end employer-sponsored GLP-1 weight-loss coverage in October

Starbucks has confirmed it will end employer-sponsored coverage for GLP-1 medications when they are prescribed for weight loss, with the change taking effect in October ^[1]. Coverage continues when the same drugs are prescribed for diabetes and other approved conditions ^[1].

The change applies to benefits-eligible employees, which at Starbucks includes workers logging at least 20 hours per week ^[1]. The company has not publicly specified, in the available reporting, how many workers use GLP-1s for weight loss or what transition support, if any, affected employees will receive — that is not yet known.

GLP-1 medications include semaglutide (sold as Ozempic and Rybelsus for type 2 diabetes and Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). A weight-loss-only exclusion of the kind Starbucks described means the drug class is still on the plan, but the reason for the prescription determines whether the plan pays ^[1].

Part of a bigger employer retreat

The Starbucks move was announced in the same week as benefit reductions at several other large employers, and it fits a pattern documented in benefits surveys ^[1]. A 2026 survey by Mercer found that 6% of large employers dropped GLP-1 weight-loss coverage in 2026, with another 5% planning to do so in 2027 ^[1].

The cost pressure behind those decisions is steep. The International Foundation of Employee Benefit Plans reported that GLP-1 drugs made up 11.4% of corporate employers' total annual health claims in 2024, up from 6.9% in 2023 ^[1]. Aon has projected a 9.5% increase in employer healthcare costs for 2027, based on data from more than 1,100 US employers covering $135 billion in health spending, which would push average per-employee spending above $19,000 — the fourth straight year of near double-digit increases ^[1].

Other companies are trimming elsewhere. Walt Disney Company will stop covering working spouses under its health plan in 2027 where those spouses can get employer coverage somewhere else, a change affecting its more than 200,000 US employees ^[1]. Bloomberg LP told employees they will start paying monthly premium contributions for the first time in company history, with an internal memo noting that its no-contribution approach had "lasted longer than any of our peers"; no contribution amounts or effective date were specified ^[1]. Deloitte is cutting paid parental leave for its "Center" talent segment from 16 weeks to eight and discontinuing a $50,000 adoption and surrogacy reimbursement program for that group, effective January 1, 2027 ^[1]. Zoom cut paid parental leave for birthing employees from 22–24 weeks to 18 weeks and for non-birthing parents from 16 weeks to 10 ^[1].

Rich Fuerstenberg, a senior partner in Mercer's health practice, summed up the employer logic to CNBC: when healthcare cost increases run into the low double-digits, everything in the benefits budget is fair game ^[1].

Why it matters for patients

For a Starbucks employee taking a GLP-1 for weight management, an exclusion like this shifts the full list price onto the patient unless another payment route exists. Cash-pay prices, manufacturer programs, and telehealth offerings are outside what these sources cover, so the practical cost gap for affected workers is not detailed here.

The diabetes carve-out matters. Because Starbucks says coverage continues for diabetes and other approved conditions ^[1], the same molecule can remain covered for one person and not for another at the same company, depending on diagnosis. That distinction is decided by the plan's rules, not the pharmacy counter.

The broader signal is that weight-loss drug coverage remains one of the least secure benefits in employer plans. With 6% of large employers dropping it in 2026 and 5% more planning to in 2027 ^[1], workers at other companies may see similar notices during open enrollment. Employers excluding a drug class are expected to give advance notice to affected employees and update plan documents and open enrollment materials before the change takes effect ^[1].

What happens next

October: the Starbucks weight-loss exclusion takes effect ^[1]. January 1, 2027: Deloitte's Center segment benefit cuts begin, and Disney's spousal coverage change applies in 2027 ^[1]. Open enrollment conversations for calendar-year plans are already underway ^[1].